Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
Aid in the diagnosis of histoplasmosis. Recommend testing in conjunction with Histoplasma Antibodies by CF & ID (0050627) and Histoplasma Galactomannan Antigen Quantitative by EIA, Urine (2009418).
MnemonicUnique test identifier.
HISTOAG S
MethodologyProcess(es) used to perform the test.
Quantitative Enzyme Immunoassay
PerformedDays of the week the test is performed.
Mon, Wed, Fri
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
1-4 days
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Collect
Plain Red or Serum Separator Tube (SST).
Specimen Preparation
Transfer 2 mL serum to a sterile ARUP Standard Transport Tube (ARUP Supply #43115). (Min: 1 mL)
Reference IntervalNormal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Not Detected
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
The quantitative range of this assay is 0.19-60.0 ng/mL. Antigen concentrations less than 0.19ng/mL or greater than 60.0 ng/mL fall outside the linear range of the assay and cannot be accurately quantified.
This EIA test should be used in conjunction with other diagnostic procedures, including microbiological culture, histological examination of biopsy samples, serology and/or radiographic evidence, to aid in the diagnosis of histoplasmosis.
Crossreactivity with Blastomyces dermatiditis, Coccidioides immitis, and possibly Talaromyces marneffei have been observed with this EIA. Other clinically and geographically relevant endemic mycoses should be considered in the case of a positive test result.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Compliance Category
Laboratory Developed Test (LDT)
NoteAdditional information related to the test.
For urine, refer to test Histoplasma Galactomannan Antigen Quantitative by EIA, Urine (ARUP test code 2009418).
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.